In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘MultipleMyeloma’ clear

  • Dr. Paul Richardson, clinical director for Dana-Farber's Jerome Lipper Center for Multiple Myeloma, shared the latest prognosis on treating and surviving this disease.

Tags: MultipleMyeloma

  • Dr. John Quackenbush discusses the collaboration of GenoSpace and the Multiple Myeloma Research Foundation to advance cancer research and development. GenoSpace provides tools for genomics research.

Tags: Genomics, MultipleMyeloma

  • Kathryn Giusti, CEO and co-founder of the Multiple Myeloma Research Foundation, discusses her work with the organization and her successful stem cell transplant performed at Dana-Farber.

Tags: MultipleMyeloma, StemCellTransplant

  • Tom Brokaw discussed his life after being diagnosed with multiple myeloma and cites Dr. Ken Anderson for being both a respected clinician and friend.

Tags: MultipleMyeloma

  • Dr. Ken Anderson discusses new targeted medicines for the treatment of myeloma. Dr. Anderson is leading an international study to determine whether these new drugs could mean risky transplants aren't needed any more.

Tags: MultipleMyeloma, TargetedTherapy

  • Dr. Paul Richardson presented recent Phase 2 clinical trial results at the International Myeloma Workshop in Kyoto, Japan.

Tags: MultipleMyeloma

  • Dr. Paul Richardson led a study showing treatment with an investigational oral drug led to stable disease or better response in three fourths of patients with heavily pretreated multiple myeloma.

Tags: MultipleMyeloma

  • A new study conducted by scientists from Dana-Farber Cancer Institute and Karolinska Institutet in Sweden, presents very promising results for the treatment of multiple myeloma.

Tags: chemotherapy, MultipleMyeloma

  • Dr. Jacob Laubach discussed his patient's diagnosis of both multiple myeloma and primary amyloidosis and the difficulty in finding a bone marrow donor.

Tags: MultipleMyeloma

  • Dr. Paul Richardson commented on the US Food and Drug Administration’s decision to expand the existing indication for lenalidomide (Revlimid) in combination with dexamethasone to include patients with newly diagnosed multiple myeloma.

Tags: MultipleMyeloma

Showing 1-10 of 16 items